臨床試験用品の市場規模、シェア、動向分析レポート：臨床フェーズ別、製品・サービス別、最終用途別、治療分野別、地域別、セグメント予測、2025年～2030年

臨床試験用品市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験用品の市場規模は2030年に41億米ドルに達すると推定され、2025年から2030年にかけてCAGRCAGR 7.19％で成長すると予測されています。

臨床試験量の増加と試験実施の複雑化は、市場成長を促進する主な要因の一つです。

世界的には、慢性疾患の有病率の増加と急速な高齢化が生物製剤の研究開発の成長を促進すると予想され、効率的な臨床供給品への需要をさらに促進し、臨床試験供給品産業の成長に貢献すると期待されています。さらに、希少疾病用医薬品の需要の増加や希少疾病の研究開発への高い投資も、生物学的製剤の開発に寄与すると予想されます。このような要因から、このセグメントは予測期間中に大きな成長を遂げる可能性が高いです。

例えば、2022年にノバルティスは研究開発に約100億米ドルを投資しました。また、欧州連合（EU）、日本、中国、米国において、新薬と希少疾患について23件の承認を取得しています。また、インドでは、非典型溶血性尿毒症症候群（aHUS）、免疫性血小板減少性紫斑病（ITP）、脊髄性筋萎縮症（SMA）、ループス腎炎などの希少疾患において、17の臨床プログラムを実施し、44の進行中の第III相プログラムを実施しています。

ダイレクト・ツー・ペイシェント（DTP）は、臨床試験用医薬品の流通において、今後の流通モデルとして期待されるセグメントです。DTPは新たなモデルの一つで、患者に直接薬剤を届け、患者中心の治験を行うものです。これにより、治験施設への訪問回数が減り、参加者の負担が軽減されます。COVID-19の発生は、最小限の混乱で臨床試験研究を継続するために、このようなモデルの採用を増加させるきっかけとなりました。さらに、患者の維持と世界中の多様な患者プールは、このモデルの高い採用率に起因する顕著な理由の一部です。

臨床試験用品市場レポートハイライト

• 臨床フェーズに基づくと、2024年の売上高シェアはフェーズIII試験が53.03%を占め、同市場が優位を占めると予測されます。現在第III相試験中の分子が多数存在することが、この減収の主因となっています。
• サービスの中では、保管・流通分野が予測期間中にCAGR 7.54%で最も急成長すると予測されています。世界の生物製剤パイプラインの増加と温度に敏感な医薬品の増加により、臨床試験用医薬品のロジスティクスに関する複雑さが増すと予想されます。
• 生物製剤は、ナノ粒子ベースのドラッグデリバリーシステムの開発など、遺伝学およびバイオテクノロジー分野の研究増加により、予測期間中にCAGR 7.48%と最も速い成長が見込まれています。
• 治療用途では、腫瘍学が2024年の売上高シェア39.59%で市場を独占しています。United Press Internationalによると、米国の病院では不適切な投与により何十億本もの抗がん剤バイアルが廃棄されており、適切な供給管理の必要性が指摘されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験用品市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 技術の進歩
  • AIとデジタル技術の統合
• 価格モデル分析
• 臨床試験件数分析、2024年
  • 地域別臨床試験総数（2024年）
  • 臨床試験の総数（フェーズ別）（2024年）
  • 臨床試験の総数（研究デザイン別）（2024年）
  • 主要治療領域別臨床試験総数（2024年）
• 市場分析ツール
  • ポーターのファイブフォース分析
  • SWOT分析によるPESTEL
  • COVID-19の影響分析

第4章 臨床試験用品市場：臨床段階別推定・動向分析

• 臨床試験用品市場（臨床段階別）：セグメントダッシュボード
• 臨床試験用品市場（臨床段階別）：変動分析
• 臨床段階別、2018年～2030年
• フェーズI
• フェーズII
• フェーズIII
• その他

第5章 臨床試験用品市場：製品・サービス別推定・動向分析

• 臨床試験用品市場（製品・サービス別）：セグメントダッシュボード
• 臨床試験用品市場（製品・サービス別）：変動分析
• 製品・サービス別、2018年～2030年
• 製造業
  • 臨床試験用品製造市場の推定とセグメント予測、2018年～2030年
  • 保管と配送
  • サプライチェーンマネジメント

第6章 臨床試験用品市場：治療領域別推定・動向分析

• 臨床試験用品市場（治療領域別）：セグメントダッシュボード
• 臨床試験用品市場（治療領域別）：変動分析
• 治療領域別、2018年～2030年
• 腫瘍学
• 中枢神経系疾患
• 心血管疾患
• 感染症
• 代謝障害
• その他

第7章 臨床試験用品市場：最終用途別推定・動向分析

• 臨床試験用品市場（最終用途別）：セグメントダッシュボード
• 臨床試験用品市場（最終用途別）：変動分析
• 用途別、2018年～2030年
• 医薬品
• 生物学的製剤
• 医療機器
• その他

第8章 臨床試験用品市場：地域別推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 世界地域市場のスナップショット
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東およびアフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
  • 市場リーダー
  • 新興企業
• 企業プロファイル
  • Almac Group
  • Biocair
  • Catalent, Inc.
  • KLIFO
  • Movianto
  • PCI Pharma Services
  • Sharp Services, LLC
  • Thermo Fisher Scientific, Inc.
  • UPS Healthcare
  • Paraxel International Corporation

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 4 Global Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 5 Global Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 6 Global Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 7 Global Clinical Trials Supplies Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 10 North America Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 11 North America Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 12 North America Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 14 U.S. Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 15 U.S. Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 16 U.S. Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 17 Canada Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 18 Canada Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 19 Canada Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 20 Canada Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 22 Mexico Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 23 Mexico Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 24 Mexico Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 25 Europe Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 27 Europe Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 28 Europe Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 29 Europe Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 30 Germany Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 31 Germany Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 32 Germany Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 33 Germany Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 34 UK Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 35 UK Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 36 UK Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 37 UK Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 38 France Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 39 France Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 40 France Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 41 France Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 42 Italy Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 43 Italy Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 44 Italy Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 45 Italy Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 46 Spain Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 47 Spain Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 48 Spain Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 49 Spain Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 50 Denmark Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 51 Denmark Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 52 Denmark Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 53 Denmark Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 54 Sweden Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 55 Sweden Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 56 Sweden Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 57 Sweden Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 58 Norway Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 59 Norway Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 60 Norway Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 61 Norway Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 67 China Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 68 China Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 69 China Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 70 China Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 71 Japan Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 72 Japan Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 73 Japan Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 74 Japan Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 75 India Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 76 India Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 77 India Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 78 India Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 79 South Korea Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 80 South Korea Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 81 South Korea Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 82 South Korea Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 83 Australia Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 84 Australia Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 85 Australia Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 86 Australia Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 87 Thailand Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 88 Thailand Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 89 Thailand Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 90 Thailand Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 91 Latin America Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
• Table 92 Latin America Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 93 Latin America Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 94 Latin America Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 95 Latin America Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 96 Brazil Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 97 Brazil Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 98 Brazil Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 99 Brazil Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 100 Argentina Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 101 Argentina Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 102 Argentina Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 103 Argentina Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 109 South Africa Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 110 South Africa Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 111 South Africa Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 112 South Africa Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 117 UAE Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 118 UAE Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 119 UAE Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 120 UAE Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
• Table 121 Kuwait Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
• Table 122 Kuwait Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
• Table 123 Kuwait Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 124 Kuwait Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Clinical Trial Supplies, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Regional Marketplace: Key Takeaways
• Fig. 12 Global Clinical Trial Supplies, for Phase I, 2018 - 2030 (USD Million)
• Fig. 13 Global Clinical Trial Supplies, for Phase II, 2018 - 2030 (USD Million)
• Fig. 14 Global Clinical Trial Supplies, for Phase III, 2018 - 2030 (USD Million)
• Fig. 15 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
• Fig. 16 Global Clinical Trial Supplies, for Manufacturing, 2018 - 2030 (USD Million)
• Fig. 17 Global Clinical Trial Supplies, for Cold Chain Distribution, 2018 - 2030 (USD Million)
• Fig. 18 Global Clinical Trial Supplies, for Non-cold Chain, 2018 - 2030 (USD Million)
• Fig. 19 Global Clinical Trial Supplies, for Storage & Distribution, 2018 - 2030 (USD Million)
• Fig. 20 Global Clinical Trial Supplies, for Supply Chain Management, 2018 - 2030 (USD Million)
• Fig. 21 Global Clinical Trial Supplies, for Pharmaceutical, 2018 - 2030 (USD Million)
• Fig. 22 Global Clinical Trial Supplies, for Biologics, 2018 - 2030 (USD Million)
• Fig. 23 Global Clinical Trial Supplies for Medical Device, 2018 - 2030 (USD Million)
• Fig. 24 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
• Fig. 25 Global Clinical Trial Supplies, for Oncology, 2018 - 2030 (USD Million)
• Fig. 26 Global Clinical Trial Supplies, for CNS Diseases, 2018 - 2030 (USD Million)
• Fig. 27 Global Clinical Trial Supplies, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
• Fig. 28 Global Clinical Trial Supplies, for Infectious Disease, 2018 - 2030 (USD Million)
• Fig. 29 Global Clinical Trial Supplies, for Metabolic Disorders, 2018 - 2030 (USD Million)
• Fig. 30 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
• Fig. 31 Regional Outlook, 2024 & 2030
• Fig. 32 North America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 U.S. Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Canada Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Mexico Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Europe Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 UK Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Germany Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 France Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Italy Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Spain Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Denmark Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Sweden Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Norway Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Asia Pacific Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 India Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 China Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Japan Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 South Korea Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Australia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Thailand Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Latin America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Brazil Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Argentina Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 MEA Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 South Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Saudi Arabia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 UAE Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Kuwait Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Clinical Trial Supplies Market Growth & Trends:

The global clinical trial supplies market size is estimated to reach USD 4.10 billion in 2030 and is anticipated to grow at a compound annual growth rate CAGR of 7.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights:

• Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 53.03% revenue share in 2024. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
• Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 7.54% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
• Biologics are expected to witness the fastest growth at 7.48% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
• In terms of therapeutic use, oncology dominated the market with a revenue share of 39.59% in 2024. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regulatory Framework

Chapter 3. Clinical Trial Supplies Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Expansion of Clinical Trials Sites
    • 3.2.1.2. Growing R&D in Biologics and Biosimilars
    • 3.2.1.3. Advancements in Supply Chain Technology
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Presence of Stringent Regulatory Policies
    • 3.2.2.2. High Possibility of Counterfeiting Drugs
• 3.3. Technological Advancements
  • 3.3.1. Integration of AI and Digital Technologies
• 3.4. Pricing Model Analysis
• 3.5. Clinical Trials Volume Analysis, 2024
  • 3.5.1. Total Number of Clinical Trials, by Region (2024)
  • 3.5.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.5.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

• 4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
• 4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
• 4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030 (USD Million)
• 4.4. Phase I
  • 4.4.1. Phase I Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 4.5. Phase II
  • 4.5.1. Phase II Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 4.6. Phase III
  • 4.6.1. Phase III Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

• 5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
• 5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
• 5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030 (USD Million)
• 5.4. Manufacturing
  • 5.4.1. Manufacturing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Storage & Distribution
    • 5.4.2.1. Downstream processing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.2. Cold Chain Distribution
      • 5.4.2.2.1. Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.3. Non-Cold Chain Distribution
      • 5.4.2.3.1. Non-Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Supply Chain Management
    • 5.4.3.1. Supply Chain Management Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
• 6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
• 6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million)
• 6.4. Oncology
  • 6.4.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.5. CNS Diseases
  • 6.5.1. CNS Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cardiovascular Diseases
  • 6.6.1. Cardiovascular Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.7. Infectious Disease
  • 6.7.1. Infectious Disease Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.8. Metabolic Disorders
  • 6.8.1. Metabolic Disorders Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Clinical Trial Supplies Market: End Use Estimates & Trend Analysis

• 7.1. Clinical Trial Supplies Market, By End Use: Segment Dashboard
• 7.2. Clinical Trial Supplies Market, By End Use: Movement Analysis
• 7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
• 7.4. Pharmaceutical
  • 7.4.1. Pharmaceutical Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 7.5. Biologics
  • 7.5.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 7.6. Medical Devices
  • 7.6.1. Medical Devices Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. China Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Japan
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Japan Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East and Africa
  • 8.8.1. Middle East and Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Profiles
  • 9.2.1. Almac Group
    • 9.2.1.1. Participant's Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Service Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. Biocair
    • 9.2.2.1. Participant's Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Service Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. Catalent, Inc.
    • 9.2.3.1. Participant's Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Service Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. KLIFO
    • 9.2.4.1. Participant's Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Service Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. Movianto
    • 9.2.5.1. Participant's Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Service Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. PCI Pharma Services
    • 9.2.6.1. Participant's Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Service Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. Sharp Services, LLC
    • 9.2.7.1. Participant's Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Service Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. Thermo Fisher Scientific, Inc.
    • 9.2.8.1. Participant's Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Service Benchmarking
    • 9.2.8.4. Strategic Initiatives
  • 9.2.9. UPS Healthcare
    • 9.2.9.1. Participant's Overview
    • 9.2.9.2. Financial Performance
    • 9.2.9.3. Service Benchmarking
    • 9.2.9.4. Strategic Initiatives
  • 9.2.10. Paraxel International Corporation
    • 9.2.10.1. Participant's Overview
    • 9.2.10.2. Financial Performance
    • 9.2.10.3. Service Benchmarking
    • 9.2.10.4. Strategic Initiatives